Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Potassium channel subfamily KQT member 5 (KCNQ5), also known as Kv7.5, is a voltage-gated potassium channel subunit that plays a critical role in regulating neuronal excitability. It contributes to the M-current, a slow-activating/deactivating potassium conductance crucial for setting the threshold for action potential firing. Mutations in KCNQ5 are associated with neurodevelopmental disorders, intellectual disability, and epilepsy, highlighting its importance in neuronal function. Its activity is modulated by various pharmacological agents, including inhibitors and activators, offering potential therapeutic avenues for related disorders.
Modulation of M-type potassium currents, influencing neuronal excitability.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium channel subfamily KQT member 5 (Kv7.5).